In search of receptor tyrosine kinase (RTK) involvement in MCC (and a rationale for the use of targeted therapies), studies have found variable expression of c-kit, VEGFs, PDGFα and PDGFβ in MCCs compared to normal skin [7,8]. This evidence concerns the gene KIT and Merkel cell skin cancer.